Frank Lyman

Frank is a medical device professional who has over 25 years’ experience with both large companies and start-up ventures. He began his career with a start-up biotechnology company and moved on to a large multinational medical device and pharmaceutical corporation based in Chicago. There, he held management positions in regulatory affairs, operations and marketing before branching out to start-up and operate a series of medical device companies. He has taken over 50 medical devices through the FDA 510(k) process.

Frank has raised over $15 million in investments for multiple companies from private investors and large corporate partners. He started SourceTech Medical, a manufacturer of radioactive seed implants to treat prostate cancer and sold the company to Bard Medical five years after inception for $39 million providing multiple returns to all investors. Frank has been a senior executive for four different medical device start-up companies before joining Lumoptik.

He earned his bachelor degree in microbiology from Michigan State University and his MBA from the Kellogg Graduate School of Management at Northwestern University.